
Oncology NEWS International
- Oncology NEWS International Vol 11 No 12
- Volume 11
- Issue 12
Feds Fund CAM Use Study
WASHINGTON-A 2-year, $1 million study by the Institute of Medicine (IOM) will explore the scientific and policy implications of complementary and alternative medicine (CAM). The study is being funded by 16 units of the National Institutes of Health, including the National Cancer Institute, and the Agency for Healthcare Research and Quality. The IOM, a part of the National Academy of Sciences, will name a committee of about 16 experts to carry out the study. Panel members will be chosen from among leading CAM specialists and more conventional disciplines.
WASHINGTONA 2-year, $1 million study by the Institute of Medicine (IOM) will explore the scientific and policy implications of complementary and alternative medicine (CAM). The study is being funded by 16 units of the National Institutes of Health, including the National Cancer Institute, and the Agency for Healthcare Research and Quality. The IOM, a part of the National Academy of Sciences, will name a committee of about 16 experts to carry out the study. Panel members will be chosen from among leading CAM specialists and more conventional disciplines.
Articles in this issue
about 23 years ago
Stereotactic Radiosurgery Benefits Brain Met Patientsabout 23 years ago
Cancer Risk From Tainted Polio Vaccine Undetermined: IOM Reportabout 23 years ago
Tailored Messages Motivate Women to Get Mammogramsabout 23 years ago
Chemo/Rituximab Is Effective as First-Line CLL Therapyabout 23 years ago
Preoperative Capecitabine/RT Downstages Rectal Cancerabout 23 years ago
Intraoperative Lymphatic Mapping Enhances Cancer Stagingabout 23 years ago
Rituximab Ups Survival in Aggressive and Indolent NHLabout 23 years ago
Genzyme Molecular Oncology Begins Kidney Cancer Vaccine Trialabout 23 years ago
Lower Breast Cancer Survival in Hispanics: New Mexico StudyNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
















































































